Shortening the Pharmaceutical R&D Lifecycle The economic reality of drug development is that most candidates fail during clinical trials, often after hundreds of millions of dollars have already been spent
In Wisconsin, a $3 billion expansion of an existing plant in Kenosha County will add injectable fill lines for tirzepatide
I'm just out here living my life
Paradells S, Zipancic I, Martnez-Losa MM, Garca Esparza M, Bosch-Morell F, Alvarez-Dolado M, et al
It's also important to note that GLP-1 receptor agonists, including semaglutide, carry an FDA-labeled risk of gallbladder disease, which can sometimes present with abnormal liver function tests